Broad white matter impairment in multiple system atrophy
- PMID: 33064319
- PMCID: PMC7776008
- DOI: 10.1002/hbm.25227
Broad white matter impairment in multiple system atrophy
Abstract
Multiple system atrophy (MSA) is a rare neurodegenerative disorder characterized by the widespread aberrant accumulation of α-synuclein (α-syn). MSA differs from other synucleinopathies such as Parkinson's disease (PD) in that α-syn accumulates primarily in oligodendrocytes, the only source of white matter myelination in the brain. Previous MSA imaging studies have uncovered focal differences in white matter. Here, we sought to build on this work by taking a global perspective on whole brain white matter. In order to do this, in vivo structural imaging and diffusion magnetic resonance imaging were acquired on 26 MSA patients, 26 healthy controls, and 23 PD patients. A refined whole brain approach encompassing the major fiber tracts and the superficial white matter located at the boundary of the cortical mantle was applied. The primary observation was that MSA but not PD patients had whole brain deep and superficial white matter diffusivity abnormalities (p < .001). In addition, in MSA patients, these abnormalities were associated with motor (Unified MSA Rating Scale, Part II) and cognitive functions (Mini-Mental State Examination). The pervasive whole brain abnormalities we observe suggest that there is widespread white matter damage in MSA patients which mirrors the widespread aggregation of α-syn in oligodendrocytes. Importantly, whole brain white matter abnormalities were associated with clinical symptoms, suggesting that white matter impairment may be more central to MSA than previously thought.
Keywords: MRI; diffusion tensor imaging; multiple system atrophy.
© 2020 The Authors. Human Brain Mapping published by Wiley Periodicals LLC.
Conflict of interest statement
Owen Phillips receives support from BrainKey. Manpreet K. Singh receives research support from Stanford's Child Health Research Institute, National Institute of Mental Health, Office of Research on Women's Health, National Institute of Aging, Neuronetics, Johnson and Johnson, and the Brain and Behavior Foundation. She has been on the advisory board for Sunovion. Olivier Rascol receives funding from Agence Nationale de la Recherche (ANR), CHU de Toulouse, France‐Parkinson, INSERM‐DHOS Recherche Clinique Translationnelle, MJFox Foundation, Programme Hospitalier de Recherche Clinique and European Commission (FP7, H2020). He has also received funding from the International Movement Disorders Society to participate in symposia and contribute to reviews. He is on the advisory board of AbbVie, Adamas, Acorda, Addex, AlzProtect, Apopharma, Astrazeneca, Bial, Biogen, Britannia, Clevexel, INC Reasearch, Lundbeck, Lupin, Merck, MundiPharma, Neuratris, Neuroderm, Novartis, Oxford Biomedica, Parexel, Pfizer, Prexton Therapeutics, Quintiles, Sanofi, Servier, Sunovion, Takeda, Teva, UCB, XenoPort and Zambon. Natalia Del Campo, Françoise Ory‐Magne, Christine Brefel‐Courbon, Monique Galitzky, Claire Thalamas, Katherine L. Narr, Shantanu Joshi, Patrice Péran, and Anne Pavy‐LeTraon have no conflicts of interest to report.
Figures




Similar articles
-
Diffusion Magnetic Resonance Imaging Microstructural Abnormalities in Multiple System Atrophy: A Comprehensive Review.Mov Disord. 2022 Oct;37(10):1963-1984. doi: 10.1002/mds.29195. Epub 2022 Aug 29. Mov Disord. 2022. PMID: 36036378 Free PMC article. Review.
-
Advanced Cognitive Patterns in Multiple System Atrophy Compared to Parkinson's Disease: An Individual Diffusion Tensor Imaging Study.Acad Radiol. 2024 Jul;31(7):2897-2909. doi: 10.1016/j.acra.2024.01.006. Epub 2024 Jan 13. Acad Radiol. 2024. PMID: 38220569
-
Abnormalities of white and grey matter in early multiple system atrophy: comparison of parkinsonian and cerebellar variants.Eur Radiol. 2019 Feb;29(2):716-724. doi: 10.1007/s00330-018-5594-9. Epub 2018 Jul 4. Eur Radiol. 2019. PMID: 29974222
-
Brain structural profile of multiple system atrophy patients with cognitive impairment.J Neural Transm (Vienna). 2017 Mar;124(3):293-302. doi: 10.1007/s00702-016-1636-0. Epub 2016 Oct 24. J Neural Transm (Vienna). 2017. PMID: 27778099
-
Voxelwise meta-analysis of gray matter anomalies in Parkinson variant of multiple system atrophy and Parkinson's disease using anatomic likelihood estimation.Neurosci Lett. 2015 Feb 5;587:79-86. doi: 10.1016/j.neulet.2014.12.007. Epub 2014 Dec 5. Neurosci Lett. 2015. PMID: 25484255
Cited by
-
Epigenetic age acceleration is associated with oligodendrocyte proportions in MSA and control brain tissue.Neuropathol Appl Neurobiol. 2023 Feb;49(1):e12872. doi: 10.1111/nan.12872. Neuropathol Appl Neurobiol. 2023. PMID: 36542090 Free PMC article.
-
Alpha-Synuclein Contribution to Neuronal and Glial Damage in Parkinson's Disease.Int J Mol Sci. 2023 Dec 26;25(1):360. doi: 10.3390/ijms25010360. Int J Mol Sci. 2023. PMID: 38203531 Free PMC article. Review.
-
Magnetic Resonance T1w/T2w Ratio in the Putamen and Cerebellum as a Marker of Cognitive Impairment in MSA: a Longitudinal Study.Cerebellum. 2023 Oct;22(5):810-817. doi: 10.1007/s12311-022-01455-8. Epub 2022 Aug 19. Cerebellum. 2023. PMID: 35982370 Free PMC article.
-
Diffusion Magnetic Resonance Imaging Microstructural Abnormalities in Multiple System Atrophy: A Comprehensive Review.Mov Disord. 2022 Oct;37(10):1963-1984. doi: 10.1002/mds.29195. Epub 2022 Aug 29. Mov Disord. 2022. PMID: 36036378 Free PMC article. Review.
-
Proximity proteomics reveals unique and shared pathological features between multiple system atrophy and Parkinson's disease.Acta Neuropathol Commun. 2025 Mar 23;13(1):65. doi: 10.1186/s40478-025-01958-5. Acta Neuropathol Commun. 2025. PMID: 40122840 Free PMC article.
References
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous